Helen Louise Collins Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Helen Louise Collins.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Helen Louise Collins. Helen Louise Collins is a EVP and Chief Medical Officer in FIVE PRIME THERAPEUTICS, INC. ($FPRX) and a SVP and Chief Medical Officer in FIVE PRIME THERAPEUTICS INC ($FPRX).

Address: C/O TWO CORPORATE DRIVE SOUTH SAN FRANCISCO 94080 CA

Companies in which Helen Louise Collins is an Insider

FIVE PRIME THERAPEUTICS, INC.

Trading Symbol: FPRX
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Helen Louise Collins: EVP and Chief Medical Officer, SVP and Chief Medical Officer
Holdings: 69,547 shares
Current Value: $3,156,043
Latest Transaction: Apr 19 2021
$FPRX Market Capitalization: $1.23B
$FPRX Previous Close: $45.38

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Latest Insider Trading Transactions of Helen Louise Collins

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Apr 19 2021FPRXFIVE PRIME THERAPE ...Collins Helen LouiseEVP and Chief Medic ...Option ExerciseD5.2590,000472,5000
Apr 19 2021FPRXFIVE PRIME THERAPE ...Collins Helen LouiseEVP and Chief Medic ...Option ExerciseD5.2590,000472,5000
Apr 19 2021FPRXFIVE PRIME THERAPE ...Collins Helen LouiseEVP and Chief Medic ...Option ExerciseD5.7820,000115,6000
Apr 19 2021FPRXFIVE PRIME THERAPE ...Collins Helen LouiseEVP and Chief Medic ...Option ExerciseD11.9758,000694,2600
Apr 19 2021FPRXFIVE PRIME THERAPE ...Collins Helen LouiseEVP and Chief Medic ...Option ExerciseD18.6950,000934,5000
Apr 19 2021FPRXFIVE PRIME THERAPE ...Collins Helen LouiseEVP and Chief Medic ...Option ExerciseD37.8960,0002,273,4000
Apr 19 2021FPRXFIVE PRIME THERAPE ...Collins Helen LouiseEVP and Chief Medic ...SellD38.00135,5475,150,7860135.5 K to 0 (-100.00 %)

View all Helen Louise Collins insider transactions.